Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP Registry

Fig. 2

Summary of mean SF-36v2 scores at baseline among treated and untreated adults with pediatric-onset HPP. aBefore the start of ERT. bBased on normative data reported in Ware et al.3 for the 1998 US general population. ERT, enzyme replacement therapy; HPP, hypophosphatasia; HRQoL, health-related quality of life; SD, standard deviation; SF-36v2, 36-item Short Form Health Survey version 2; US, United States

Back to article page